157 — Natural Beauty Bio-Technology Income Statement
0.000.00%
- HK$1.00bn
- HK$1.02bn
- HK$336.02m
- 61
- 24
- 24
- 26
Annual income statement for Natural Beauty Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 438 | 411 | 488 | 336 | 336 |
Cost of Revenue | |||||
Gross Profit | 266 | 240 | 306 | 189 | 200 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 400 | 400 | 438 | 355 | 340 |
Operating Profit | 38.3 | 10.6 | 50.3 | -19.2 | -3.74 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 37 | 8.98 | 48.5 | -23.5 | -11.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.9 | 7.76 | 35.3 | -30.5 | -15.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 21.9 | 7.76 | 35.3 | -30.5 | -15.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21.9 | 7.76 | 35.3 | -30.5 | -15.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.012 | 0.005 | 0.018 | -0.013 | -0.008 |
Dividends per Share |